BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
|
|
BOM : 524663     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Average [Stock is fairly valued] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
May 31,2023 |
Price(EOD): βΉ 22.84
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: βΉ 98.67 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | 0.9% | -4.2% | -18.2% |
SUN PHARMACEUTICAL INDUSTRIES | 3.4% | 0.4% | 6.5% |
DIVIS LABORATORIES | 0.5% | 6.1% | 0.3% |
CIPLA | 1% | 4.2% | -0.5% |
DR REDDYS LABORATORIES | 0% | -9.1% | 5% |
TORRENT PHARMACEUTICALS | 8.4% | 11.4% | 18.2% |
ABBOTT INDIA | -0.5% | -3% | 24.7% |
ZYDUS LIFESCIENCES | -0.7% | -2.8% | 35.6% |
ALKEM LABORATORIES | 1% | -4.3% | 11.1% |
FUNDAMENTAL ANALYSIS OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
-7.53
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -13.10 Cr
[Latest Qtr - Dec2022 - Standalone Results ] 0.94
P/B Calculated based on Book Value of Rs 105.35 Cr
[Latest Year - Mar2022 - Standalone Results ] 1.81
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Dec2022 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
NA NA (-ve EV) 18% |
SHARE PRICE MOMENTUM OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION vs SENSEX
DEBT OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
-12.18 11.56 0.15 -0.16 |
- - - - |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-100% -89.08% -59.89% -51.96% |
-100% -35.41% -38.85% 49.95% |
QtrlyTrend |
-6 | |
Latest Qtr: Dec2022 | ||
Quarterly Result Analysis → |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION related INDICES
You may also like the below Video Courses
FAQ about BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Is BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION good for long term investment?
As on May 31,2023, the Fundamentals of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION look Poor and hence it may not be good for long term investment ! See Financial Performance of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION UnderValued or OverValued?
As on May 31,2023, BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION ?
As on May 31,2023, the Intrinsic Value of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is Rs. 19.36 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. -12.05
Fair Value [Median EV / Sales Model] : Rs. -0.11
Fair Value [Median Price / Sales Model] : Rs. 19.36
Estimated Median Fair Value of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION : Rs. 19.36
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION trading at a Premium or Discount?
As on May 31,2023, BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is trading at a Premium of 18% based on the estimates of Median Intrinsic Value!